Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biospecifics Tech Cp
(NQ:
BSTC
)
88.53
USD
UNCHANGED
Last Price
Updated: 4:21 PM EST, Dec 1, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Biospecifics Tech Cp
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
The Daily Biotech Pulse: Foamix Jumps on Data, Positive Results for Galapagos-Gilead's Rheumatoid Arthritis Drug, Bausch Health Trims Debt
September 12, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ...
Tags
KRYS
CNST
KALA
From
Benzinga
The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet
September 11, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Stocks that hit 52-week ...
Tags
PTX
Offerings
SSKN
From
Benzinga
5 Top-Ranked Nasdaq Stocks Defying the Worst September Start
September 10, 2018
After peaking at the end of the last month, the Nasdaq Composite Index logged in the fourth straight decline last week, slumping 2.6% -- the worst start to September since 2008.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Biospecifics Tec Shares Up 26.0% Since SmarTrend's Buy Recommendation (BSTC)
September 04, 2018
SmarTrend identified an Uptrend for Biospecifics Tec (NASDAQ:BSTC) on March 12th, 2018 at $42.50. In approximately 6 months, Biospecifics Tec has returned 25.95% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences
August 30, 2018
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed...
From
PR Newswire
IBD Stock Of The Day: Vertex Pharma Nears Third Breakout Of 2018
August 21, 2018
Vertex Pharmaceuticals is the IBD Stock Of The Day as shares near a breakout amid a flurry of recent news surrounding its cystic fibrosis treatments.
From
Investor's Business Daily
Market Trends Toward New Normal in Addus HomeCare, Sandstorm Gold, BioSpecifics Technologies, Itau Unibanco Holding S.A, Akers Biosciences, and Kosmos Energy — Emerging Consolidated Expectations, Anal
August 21, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Addus HomeCare Corporation...
From
GlobeNewswire News Releases
Biospecifics Tec Has Returned 22.0% Since SmarTrend Recommendation (BSTC)
August 14, 2018
SmarTrend identified an Uptrend for Biospecifics Tec (NASDAQ:BSTC) on March 12th, 2018 at $42.50. In approximately 5 months, Biospecifics Tec has returned 21.95% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
Biospecifics Technologies Joins Rank Of Stocks With 95-Plus Composite Rating
August 13, 2018
Biospecifics Technologies saw its IBD SmartSelect Composite Rating jump to 96 Tuesday, up from 92 the day before.
From
Investor's Business Daily
BioSpecifics Technologies Corp. Reports Second Quarter 2018 Financial Results
August 09, 2018
- Phase 1 trial of CCH for treatment of Uterine fibroids now fully enrolled -
From
PR Newswire
Biospecifics Technologies Corp. Breaks Below 200-Day Moving Average - Notable for BSTC
August 03, 2018
In trading on Friday, shares of Biospecifics Technologies Corp. (BSTC) crossed below their 200 day moving average of $43.42, changing hands as low as $43.06 per share..
Tags
Stocks
From
Market News Video
Investor Expectations to Drive Momentum within Capital Product Partners, Nova Measuring Instruments, BioSpecifics Technologies, Itau Unibanco Holding S.A., CNB Financial, and Laureate Education — Disc
June 06, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Capital Product Partners...
From
GlobeNewswire News Releases
Bullish Two Hundred Day Moving Average Cross - BSTC
June 05, 2018
In trading on Tuesday, shares of Biospecifics Technologies Corp. (BSTC) crossed above their 200 day moving average of $43.85, changing hands as high as $44.33 per share..
Tags
Stocks
From
Market News Video
Look Under The Hood: PXSG Has 13% Upside
May 15, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
BRIEF-Biospecifics Technologies Reports Q1 Earnings Per Share $0.54
May 09, 2018
* BIOSPECIFICS TECHNOLOGIES CORP. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
Tags
companyNews
From
Reuters: Company News
BioSpecifics Technologies Corp. Reports First Quarter 2018 Financial Results
May 09, 2018
- Continued year-over-year revenue growth for XIAFLEX -
From
PR Newswire
New Research: Key Drivers of Growth for Talend S.A, Chipmos Technologies, POSCO, Horizon Pharma Public, BioSpecifics Technologies, and Arbutus Biopharma — Factors of Influence, Major Initiatives and S
April 11, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Talend S.A. (NASDAQ:TLND),...
From
GlobeNewswire News Releases
Analysts Predict 17% Gains Ahead For PXSG
April 10, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
New Research: Key Drivers of Growth for CNB Financial, Akebia Therapeutics, Mesoblast, 21Vianet Group, Old Line Bancshares, and BioSpecifics Technologies — Factors of Influence, Major Initiatives and
March 16, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CNB Financial Corporation...
From
GlobeNewswire News Releases
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
March 14, 2018
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
BioSpecifics Technologies Corp. Announces Presentation of Interim Data from Phase 1 Study of CCH for the Treatment of Uterine Fibroids at 65th Annual Scientific Meeting of the Society for Reproductive
March 12, 2018
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
How The Parts Add Up: PXSG Headed For $39
February 23, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Biospecifics Tec Down 15.7% Since SmarTrend Downtrend Call (BSTC)
February 20, 2018
SmarTrend identified a Downtrend for Biospecifics Tec (NASDAQ:BSTC) on August 10th, 2017 at $46.31. In approximately 6 months, Biospecifics Tec has returned 15.73% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
BioSpecifics Technologies Corp. to Present at the NobleCon14 Conference
January 22, 2018
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
BRIEF-Biospecifics Technologies reports Q3 eps of $0.37
November 10, 2017
* Biospecifics Technologies Corp reports Q3 2017 financial results
Tags
companyNews
From
Reuters: Company News
BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results
November 10, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
BioSpecifics Technologies Corp. to Present at the Stifel 2017 Healthcare Conference
November 07, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
Analysts Anticipate PXSG To Hit $36
September 26, 2017
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
BioSpecifics Technologies Corp. to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
September 20, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences
September 05, 2017
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed...
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.